Hughes D, McGuire A
Department of Economics, City University, London, UK.
Health Econ. 1995 May-Jun;4(3):213-20. doi: 10.1002/hec.4730040306.
Since the inception of the NHS, user charges have been present for prescription medication. However since 1968 there has been a steady increase in this charge, particularly notable during the 1980s. The main justification for user charges is their revenue raising potential, and a recent government report has backed the use of user charges for prescription drugs. Whilst there is extensive evidence of the impact of user charges on utilisation of health care in the US, few studies exist in the UK. An accurate estimation of the price elasticity of utilisation is necessary if the full consequences of user charges are to be examined. This paper uses a cointegration estimation technique to estimate the price elasticity for prescription drug utilisation in the UK.
自国民健康服务体系(NHS)成立以来,一直对处方药收取用户费用。然而,自1968年以来,这项费用一直在稳步上涨,在20世纪80年代尤为显著。收取用户费用的主要理由是其增加收入的潜力,最近一份政府报告支持对处方药收取用户费用。虽然在美国有大量关于用户费用对医疗保健利用影响的证据,但在英国这类研究却很少。如果要全面考察用户费用的后果,就必须准确估计利用的价格弹性。本文采用协整估计技术来估计英国处方药利用的价格弹性。